Corbus Pharmaceuticals (0SZI) Share Forecast & Price Target
0SZI Analyst Ratings
0SZI Stock 12 Month Forecast
Average Price Target
$35.17▲(747.80% Upside)Detailed List of Analyst Forecasts
| Analyst Profile | Expert Firm | Price Target | Position | Upside / Downside | Action | Date | Follow | Article |
|---|---|---|---|---|---|---|---|---|
| Graig Suvannavejh | Mizuho Securities | $33→$24 | buy | 478.59%Upside | Reiterated | 10/29/26 | ||
| Andres Y. Maldonado | H.C. Wainwright | $35 | buy | 743.78%Upside | Reiterated | 09/15/26 | ||
| Robert Driscoll | Wedbush | $30 | buy | 623.24%Upside | Reiterated | 09/15/26 | ||
| Oliver McCammon | LifeSci Capital | $38 | buy | 816.10%Upside | Reiterated | 09/14/26 | ||
| Andy Hsieh | William Blair | ― | buy | ― | Reiterated | 09/14/26 | ||
| Brian Abrahams | RBC Capital | $36 | buy | 767.89%Upside | Reiterated | 08/12/26 | ||
| Jeff Jones | Oppenheimer | $52→$48 | buy | 1057.18%Upside | Reiterated | 08/07/26 | ||
| Paul Jeng | Guggenheim | $45 | buy | 984.86%Upside | Reiterated | 06/02/26 | ||
| Maury Raycroft | Jefferies | $36→$33 | buy | 695.56%Upside | Reiterated | 05/12/26 | ||
 Unknown AnalystNot Ranked | B. Riley Securities | $28 | buy | 575.02%Upside | Reiterated | 04/10/26 |
| Analyst Profile | Date | Price Target | Position | Upside / Downside | Action | Follow | Article | Expert Firm |
|---|---|---|---|---|---|---|---|---|
| Graig Suvannavejh | 10/29/26 | $33→$24 | buy | 478.59%Upside | Reiterated | Mizuho Securities | ||
| Andres Y. Maldonado | 09/15/26 | $35 | buy | 743.78%Upside | Reiterated | H.C. Wainwright | ||
| Robert Driscoll | 09/15/26 | $30 | buy | 623.24%Upside | Reiterated | Wedbush | ||
| Oliver McCammon | 09/14/26 | $38 | buy | 816.10%Upside | Reiterated | LifeSci Capital | ||
| Andy Hsieh | 09/14/26 | ― | buy | ― | Reiterated | William Blair | ||
| Brian Abrahams | 08/12/26 | $36 | buy | 767.89%Upside | Reiterated | RBC Capital | ||
| Jeff Jones | 08/07/26 | $52→$48 | buy | 1057.18%Upside | Reiterated | Oppenheimer | ||
| Paul Jeng | 06/02/26 | $45 | buy | 984.86%Upside | Reiterated | Guggenheim | ||
| Maury Raycroft | 05/12/26 | $36→$33 | buy | 695.56%Upside | Reiterated | Jefferies | ||
| Unknown AnalystNot Ranked | 04/10/26 | $28 | buy | 575.02%Upside | Reiterated | B. Riley Securities |
Best Analysts Covering Corbus Pharmaceuticals
Copying Andy Hsieh's trades and holding each position for 3 Months would result in 46.15% of your transactions generating a profit, with an average return of -5.12% per trade.
Copying Andy Hsieh's trades and holding each position for 1 Year would result in 30.77% of your transactions generating a profit, with an average return of -27.60% per trade.
Copying Andy Hsieh's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -52.52% per trade.
0SZI Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 26 | 19 | 12 | 12 | 13 |
| Buy | 4 | 3 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 30 | 22 | 14 | 14 | 15 |
In the current month, 0SZI has received 15 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0SZI average Analyst price target in the past 3 months is 35.17.
0SZI Financial Forecast
0SZI Earnings Forecast
Next quarter’s earnings estimate for 0SZI is -$1.27 with a range of -$1.91 to -$0.73. The previous quarter’s EPS was -$1.81. 0SZI beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0SZI has Performed in-line its overall industry.
0SZI Sales Forecast
Next quarter’s sales forecast for 0SZI is $1.67M with a range of $0 to $10.00M. The previous quarter’s sales results were $0. 0SZI beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0SZI has Performed in-line its overall industry.